Susquehanna International Group’s Autolus Therapeutics AUTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$551K	Sell	399,143 -199,844	-33%	-$304K	﹤0.01%	9409
2025 Q4	$1.19M	Buy	598,987 +363,159	+154%	+$558K	﹤0.01%	6791
2025 Q3	$384K	Buy	235,828 +15,259	+7%	+$29.8K	﹤0.01%	9566
2025 Q2	$503K	Buy	220,569 +153,514	+229%	+$254K	﹤0.01%	9166
2025 Q1	$104K	Sell	67,055 -3,836	-5%	-$7.79K	﹤0.01%	11516
2024 Q4	$167K	Buy	70,891 +50,187	+242%	+$170K	﹤0.01%	10930
2024 Q3	$75.2K	Buy	20,704 +301	+1%	+$1.2K	﹤0.01%	11198
2024 Q2	$71K	Sell	20,403 -50,816	-71%	-$219K	﹤0.01%	11239
2024 Q1	$454K	Buy	71,219 +18,215	+34%	+$114K	﹤0.01%	8731
2023 Q4	$341K	Buy	+53,004	New	+$202K	﹤0.01%	9557
2023 Q2	–	Sell	-38,947	Closed	-$92.4K	–	12044
2023 Q1	$71.7K	Buy	38,947 +18,744	+93%	+$36.6K	﹤0.01%	11518
2022 Q4	$38.4K	Buy	20,203 +8,063	+66%	+$20.4K	﹤0.01%	11534
2022 Q3	$26K	Sell	12,140 -4,477	-27%	-$13.3K	﹤0.01%	12505
2022 Q2	$47K	Buy	+16,617	New	+$50.6K	﹤0.01%	12008
2022 Q1	–	Sell	-15,670	Closed	-$65.9K	–	12960
2021 Q4	$81K	Buy	+15,670	New	+$94K	﹤0.01%	12274